Cardiovascular Disorders

Course Instructor Pharm Prep

To enroll in this course, please contact the Admin

Module Overview

Sub-Modules

1 Subject

Cardiovascular

11 Exercises • 169 Learning Materials

Coronary Artery Disease / Stable Angina

Introduction

Investigations

Nonpharmacologic choices

Drugs that Decrease or Prevent Angina

Drugs That Decrease the Risk of Cardiovascular Death and Nonfatal MI

Drugs that Increase the Risk of Cardiovascular Death and Nonfatal MI

Treating - Modifiable Risk Factors

Drug Table - Nitrates

Drug Table - Antiplatelet Agents

Drug Table - Antianginal

Drug Table - Beta1-Adrenergic Antagonists

Drug Table - Calcium Channel Blockers

Algorithms - Management of Stable Angina Pectoris

Image

Coronary Artery Disease

Exercise

Acute Coronary Syndromes & Myocardial Infarction

Introduction

Investigations

Therapeutic Choices: UA / NSTEMI

Therapeutic Choices: STEMI

Drug Table - Angiotensin-Converting Enzyme (ACE) Inhibitors

Drug Table - Antiplatelet Agents

Drug Table - Fibrinolytics

Drug Table - Beta1-adrenergic Antagonists.

Drug Table - Calcium Channel Blockers

Drug Table - Heparin / Fondaparinux

Drug Table - Mineralocorticoid Receptor Antagonists

Drug Table - Nitrates

Complications of STEMI

Choices during Pregnancy and Breastfeeding

Algorithms - Management of UA / NSTEMI

Image

Algorithms - Management of STEMI

Image

Acute Coronary Syndromes & Myocardial Infarction

Exercise

Dyslipidemia

Introduction

Investigations

Criteria for Intervention

Framingham Heart Study (Estimating the 10-Year Risk of CVD)

Image

Nonpharmacologic Choices

Pharmacologic Choices

HMG-CoA Reductase Inhibitors (Statins)

Statin – Indications / Adverse Effects

Cholesterol Absorption Inhibitors

Fibrates

Resins

Icosapent Ethyl

PCSK9 Inhibitors

Microsomal Triglyceride Transfer Protein Inhibitors

Nicotinic Acid (Niacin)

Nonprescription Agents

Choices during Pregnancy and Breastfeeding

Algorithm – Management of dyslipidemia

Image

Algorithm – Management of Statin induced myopathy

Image

Dyslipidemia

Exercise

Hypertension

Introduction

Investigations

Diagnosis

Nonpharmacologic Choices

Pharmacologic Choices

Diuretics

Angiotensin-Converting Enzyme Inhibitors

Angiotensin II Receptor Blockers

Direct Renin Inhibitors

Calcium Channel Blockers

Beta1-Adrenergic Antagonists

Other Antihypertensive Drugs

Combination Therapy

Drug Tables - Combination Therapy

Individualization of Antihypertensive Therapy

Adherence / Resistant Hypertension / Hypertensive Emergencies

Choices during Pregnancy and Breastfeeding

Algorithm - Diagnosis of Hypertension

Image

Hypertension

Exercise

Heart Failure

Introduction

Investigations

Natriuretic Peptide / Diagnosis of Heart Failure

Factors That Can Exacerbate Heart Failure

Nonpharmacologic Choices:

Treatment Decisions

Pharmacologic Choices - Diuretics

Agents to Treat Heart Failure with Reduced Ejection Fraction

Outcomes - Drugs Used for Heart Failure with Reduced Ejection Fraction

Agents to Treat Heart Failure with Preserved Ejection Fraction

Drug Table - Angiotensin-Converting Enzyme Inhibitors

Drug Table - Angiotensin II Receptor Antagonists

Drug Table - Angiotensin Receptor-Neprilysin Inhibitor Combination

Drug Table - Beta1-adrenergic Antagonists

Drug Table - If Current Inhibitor

Drug Table - Inotropic Agents

Drug Table - Loop Diuretics

Drug Table - Mineralocorticoid Receptor Antagonists (MRAs)

Drug Table - Sodium-Glucose Cotransporter 2 Inhibitors

Drug Table - Thiazides and Related Diuretics

Drug Table – Vasodilators

Choices during Pregnancy and Breastfeeding

Algorithm - Evaluation of Patients with Heart Failure

Image

Algorithm - Management of Heart Failure with Preserved Ejection Fraction

Image

Heart Failure

Exercise

Stroke

Introduction

Investigations

Nonpharmacologic Choices - Acute Ischemic Stroke

Pharmacologic Choices - Ischemic Stroke

Table - Drugs Used to Treat Acute Ischemic Stroke

Thrombolysis in Acute Ischemic Stroke: Treatment Criteria

Thrombolysis in Acute Ischemic Stroke: Monitoring

Choices During Pregnancy and Breastfeeding

Hemorrhagic Stroke - Pharmacologic Choices

Subarachnoid Hemorrhage - Pharmacologic Choices

Table - Drugs Used to Treat Subarachnoid Hemorrhage

Prevention of Ischemic Stroke

Investigations - Prevention of Ischemic Stroke

Nonpharmacologic Choices - Prevention of Ischemic Stroke

Pharmacologic Choices - Prevention of Ischemic Stroke

Table - Drugs Used in Secondary Prevention of Stroke

Choices during Pregnancy and Breastfeeding

Algorithm - General Management of the Stroke Patient

Image

Algorithm - ED - Management of Patients with Suspected Stroke

Image

Algorithm – Secondary Prevention of Cerebral Ischemia

Image

Stroke

Exercise

Arrhythmias

Introduction - Ventricular Tachyarrhythmias

Investigations (VT/VF)

Significance of VT/VF

QT Prolongation and Arrhythmia Risk

Medications and QT Prolongation

Nonpharmacologic Choices (VT/VF)

Pharmacologic Choices (VT/VF)

Drug Table - Beta1-Adrenergic Antagonists - VT/ VF

Drug Table - Antiarrhythmics - VT/ VF

Algorithm - Management of Nonsustained Ventricular Tachycardia

Image

Algorithm - Long-Term Management of Sustained Ventricular Tachycardia

Image

Introduction - Supraventricular Tachycardia (SVT)

Investigations (SVT)

Nonpharmacologic Choices (SVT)

Long-Term Management of Atrial Fibrillation or Atrial Flutter

Heart Rate Control in Patients with Persistent or Permanent Atrial Fibrillation or Atrial Flutter

Anticoagulation for Paroxysmal, Persistent, and Permanent Atrial Fibrillation or Atrial Flutter

Management of Re-entrant Tachycardias and Focal Atrial Tachycardia

Table - Drug Therapy for Control of Heart Rhythm in Patients with SVT

Table - Drug Therapy for Control of Heart Rate in Patients with SVT

Table - Drug Therapy - Prevention of Systemic Embolism in Patients with SVT

Algorithm - Rate versus Rhythm Control for Patients with Symptomatic Atrial Fibrillation

Image

Arrhythmias

Exercise

DVT, PE, Anticoagulation

Introduction

Investigations

General Measures / Nonpharmacologic Choices

Pharmacologic Choices

Table - Direct Factor Xa Inhibitors

Table - Direct Thrombin Inhibitors

Table - Indirect Factor Xa Inhibitors

Table - Low Molecular Weight Heparins

Table - Unfractionated Heparin

Table - Vitamin K Antagonists

Prophylaxis of Venous Thromboembolism

Table - Antiplatelet Agents - Prophylaxis of VTED

Table - Direct Factor Xa Inhibitors - Prophylaxis of VTED

Table - Direct Thrombin Inhibitors - Prophylaxis of VTED

Table - Indirect Factor Xa Inhibitors - Prophylaxis of VTED

Table - Low Molecular Weight Heparins - Prophylaxis of VTED

Table - Unfractionated Heparin - Prophylaxis of VTED

Choices during Pregnancy and Breastfeeding

Algorithm - Long-Term Treatment of Venous Thromboembolism

Image

Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Anticoagulation

Exercise

Intermittent Claudication

Introduction

Investigations

Nonpharmacologic Choices

Pharmacologic Choices

Specific Therapy for Intermittent Claudication

Table - Drug Therapy for Intermittent Claudication

Intermittent Claudication

Exercise

Raynaud's Phenomenon

Introduction

Investigations

Nonpharmacologic Choices

Pharmacologic Choices

Drugs Implicated in Secondary Raynaud Phenomenon

Table - Drugs Used for the Treatment of Raynaud Phenomenon

Choices during Pregnancy and Breastfeeding

Raynaud's Phenomenon

Exercise

Syncope

Introduction

Investigations

Vasovagal Syncope

Orthostatic Hypotension

Table - Drugs for Treatment of Syndromes of Orthostatic Intolerance

Syncope

Exercise